
|Slideshows|April 5, 2019
7 New Drugs for Neurologists
Author(s)Julie Bowen
Here’s a brief look at therapies for neurological disorders that the FDA has approved within the past 6 months.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine More Effective Than S1P Receptor Modulators in Treating Relapsing-Remitting MS, Study Shows
2
FDA Adds Boxed Warning, Narrows Indication for DMD Gene Therapy
3
BBP-418 Success in LGMD, Alixorexton Improves Narcolepsy Symptoms, Fenebrutinib Meets Phase 3 End Points
4
NeurologyLive® Brain Games: November 16, 2025
5



































